This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (27)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA

Debunking the "Only 50%" Myth

John G. Canto, MD, MSPH; Ami E. Iskandrian, MD

JAMA. 2003;290:947-949.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Conventional wisdom (or misconception) holds that the 4 major modifiable traditional cardiovascular risk factors—smoking, diabetes mellitus, hypertension, and hypercholesterolemia—account for "only 50%" of those who go on to develop coronary heart disease (CHD),^1-2 even though the original source of this claim is not well documented. Thus, over the past decade, a search to discover novel markers and other nontraditional risk factors to assess cardiovascular risk has come to the forefront.

In 2 separate articles in this issue of THE JOURNAL, Khot et al³ and Greenland et al⁴ examined data from 14 randomized clinical trials (n = 122 458) and 3 observational studies (n = 386 915), respectively, and directly challenge this "only 50%" claim. The investigators report that 80% to 90% of patients who developed clinically significant CHD and more than 95% of patients who experienced a fatal CHD event in fact . . . [Full Text of this Article]

Author Affiliations: Chest Pain Center, Division of Cardiovascular Diseases, University of Alabama at Birmingham.

RELATED ARTICLES

Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Philip Greenland, Maria Deloria Knoll, Jeremiah Stamler, James D. Neaton, Alan R. Dyer, Daniel B. Garside, and Peter W. Wilson
JAMA. 2003;290(7):891-897.
ABSTRACT | FULL TEXT  

Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Umesh N. Khot, Monica B. Khot, Christopher T. Bajzer, Shelly K. Sapp, E. Magnus Ohman, Sorin J. Brener, Stephen G. Ellis, A. Michael Lincoff, and Eric J. Topol
JAMA. 2003;290(7):898-904.
ABSTRACT | FULL TEXT  

Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Daniel G. Hackam and Sonia S. Anand
JAMA. 2003;290(7):932-940.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence trends for myocardial infarction and conventional risk factors among Greek adults (2002-06)
Gikas et al.
QJM 2008;0:hcn076v1-hcn076.
ABSTRACT | FULL TEXT  

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories
Vrijens et al.
BMJ 2008;336:1114-1117.
ABSTRACT | FULL TEXT  

Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
McGill et al.
Circulation 2008;117:1216-1227.
FULL TEXT  

Reassessing normal blood pressure
Nash
BMJ 2007;335:408-409.
FULL TEXT  

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
Brusq et al.
J. Lipid Res. 2006;47:1281-1288.
ABSTRACT | FULL TEXT  

Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
Yang et al.
Circulation 2006;113:1335-1343.
ABSTRACT | FULL TEXT  

Traditional CHD Risk Factors: Still the Ones to Watch
Journal Watch Cardiology 2003;2003:4-4.
FULL TEXT